BioCentury
ARTICLE | Company News

Epidauros, Bayer in drug metabolism deal

May 23, 2001 7:00 AM UTC

Epidauros (Munich, Germany) will screen preclinical compounds provided by Bayer (Frankfurt:BAYG) using its assay for identifying drug-induced stimulation of cytochrome P450 3A4 enzyme ( CYP3A4). CYP3A...